Search: onr:"swepub:oai:lup.lub.lu.se:3c10ff6f-bb91-4e77-8455-aa3630271d48" >
New players in chro...
New players in chronic lung disease identified at the European Respiratory Society International Congress in Paris 2018 : From microRNAs to extracellular vesicles
-
- Burgy, Olivier (author)
- University of Colorado
-
- Fernandez, Elena Fernandez (author)
- Royal College of Surgeons in Ireland,Beaumont Hospital, Dublin
-
- Enes, Sara Rolandsson (author)
- Lund University,Lunds universitet,Lungbiologi,Forskargrupper vid Lunds universitet,Lung Biology,Lund University Research Groups,University of Vermont
-
show more...
-
- Königshoff, Melanie (author)
- University of Colorado
-
- Greene, Catherine M. (author)
- Beaumont Hospital, Dublin,Royal College of Surgeons in Ireland
-
- Bartel, Sabine (author)
- Research Center Borstel
-
show less...
-
(creator_code:org_t)
- 2018-09
- 2018
- English.
-
In: Journal of Thoracic Disease. - : AME Publishing Company. - 2072-1439 .- 2077-6624. ; 10, s. 2983-2987
- Related links:
-
http://dx.doi.org/10... (free)
-
show more...
-
https://doi.org/10.2...
-
https://lup.lub.lu.s...
-
https://doi.org/10.2...
-
show less...
Abstract
Subject headings
Close
- Since the first description of microRNAs (miRNAs) in 1993 (1) a large and growing number of studies has explored their roles across a variety of biomedical research disciplines, including lung biology. According to GENCODE (version 27) (2), 1881 of the >7,500 human small non-coding RNAs are miRNAs. These 20–25 nucleotide-long, regulatory RNAs are involved in the translational regulation of gene expression principally via binding to miRNA recognition elements largely in the 3' untranslated regions of target mRNAs. Upon binding they can induce mRNA degradation, deadenylation or inhibition of their translation, leading to decreased target gene expression (3). Originally described to play important roles in developmental biology, miRNAs have since been found to have significant roles in a multitude of biological processes. Expression levels of miRNAs vary greatly between cells and tissues, and aberrant levels of miRNA are associated with many diseases in humans. In fact, these non-coding RNA molecules are now recognized as major regulators in the development and progression of various chronic lung diseases, including cystic fibrosis (CF), idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD) and asthma (4-9).
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Lungmedicin och allergi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Respiratory Medicine and Allergy (hsv//eng)
Publication and Content Type
- art (subject category)
- ref (subject category)
Find in a library
To the university's database